Andrew Martin

Head Of Investment Product Strategy at GMO

Andrew Martin has a comprehensive work experience in the investment industry. Andrew started their career at Donaldson, Lufkin & Jenrette as an Equity Research Associate and later became a Vice President in Equity Research. Andrew then moved to Credit Suisse First Boston as a Vice President in Equity Research as well. Andrew joined Cambridge Associates in 2006, where they held the positions of Managing Director - Investments and Head of Global Hedge Fund Research. During their time at Cambridge Associates, Andrew led multiple investment teams and managed client relationships with assets ranging from $100m to $5bn. In 2017, Andrew joined GMO as the Head of Investment Teams, where they oversaw equities, fixed income, and alternatives teams, as well as trading, product development, and marketing. Andrew was also a member of the management team, reporting directly to the CEO. In 2020, they transitioned to the role of Head of Investment Product Strategy at GMO.

Andrew Martin completed their Bachelor of Arts degree in Political Science and International Studies at Yale University from 1993 to 1997. Later, from 2004 to 2006, they pursued a Master of Business Administration degree with a focus on Business at The Tuck School of Business at Dartmouth.



  • Head Of Investment Product Strategy

    August, 2020 - present

  • Head Of Investment Teams

    January, 2017

View in org chart